Pharma Journalist -

The US Food and Drug Administration (FDA) has accepted for priority review Bristol-Myers Squibb's supplemental biologics license application (sBLA) for Opdivo (nivolumab) in previously…
Read More...

Virtus Pharmaceuticals has filed a lawsuit against the US Food and Drug Administration (FDA) and Department of Health and Human Services (HHS), seeking to prevent a monopoly, and…
Read More...

VBL Therapeutics has entered in to a long-term lease contract for a new stand-alone facility in Modiin, Israel. The site will house VBL's local biological drugs manufacturing facility,…
Read More...

IBM announced that many IBM U.S. employees fighting cancer will be able to tap into Watson for insights into their cancer treatment as well as potential clinical trial options. Through…
Read More...

Nexus BioPharma has signed an agreement to license TransChem's transition state chemistry technology for kinase inhibition. Kinases are enzymes that regulate essential cellular…
Read More...

Codexis has completed the second and final phase in the transfer of its CodeEvolver protein engineering platform technology to Merck, known as MSD outside the US and Canada, under a…
Read More...

Pilgrim Quality Solutions announced the validated release of Smart Solve Out Of Specification Management (OOS) Management. Pilgrim’s out-of-specification software drives consistent OOS…
Read More...

Judge Claire C. Cecchi of the United States District Court for the District of New Jersey has ruled in favor of Depomed in the company's patent litigation against all three filers of…
Read More...

Bayer and DelSiTech Ltd., a Finnish drug delivery technology and drug development company, have signed a Collaboration and Technology Licence Agreement for the worldwide application of…
Read More...

Pharmaron has entered into a non-binding Heads of Terms (HoTs) with Merck Sharp & Dohme Limited (MSD) for the sale of the Hoddesdon UK site which includes MSD’s process development…
Read More...